北美皮内注射市场预测至 2028 年 - COVID-19 影响和按方法（正常尺寸针、短针和无针）、应用（结核菌素皮肤测试、过敏测试、局部美学等）和最终用户进行的区域分析（医院、诊断实验室、学术和研究机构等）
No. of Pages: 121 | Report Code: TIPRE00027994 | Category: Life Sciences
No. of Pages: 121 | Report Code: TIPRE00027994 | Category: Life Sciences
制造商的战略发展预计将推动市场
<北美皮内注射剂市场的制造商正在采取合作伙伴关系、协作、产品发布、审批和并购等策略来维持竞争。他们还注重建立合作伙伴关系，以加强其在市场上的影响力，并促进临床研究，以加速新药的开发。例如，2021年1月，Pharmajet与美国陆军传染病医学研究所（USAMRIID）合作，旨在利用Pharmajet无针喷射注射器提供USAMRIID开发的治疗天花的基因疗法；该疗法以 4pox 的名称在市场上销售。此外，Inviragen 和 PharmaJet 的合作获得了 1550 万美元的投资，用于研究性登革热疫苗（DENVax），通过 Pharmajet 的无针注射装置进行注射。此外，Crossject 和 Cenexi 于 2016 年合作开发了一款名为 Zeneo 的无针自动注射器。因此，北美的医疗设备制造商正在扩大其设备的生产规模，同时推出创新产品并确保其产品的容易获得。此外，监管机构正在通过及时的产品批准和许可来提供所需的支持。对制造商来说的这种有利条件正在促进北美皮内注射市场的增长。
市场概况
美国、加拿大和墨西哥是北美皮内注射剂市场的主要贡献者。美国是该地区市场的最大贡献者，美国市场的增长归因于结核病、过敏等发病率增加等因素；国内正在进行全面的临床研究和合同研究；以及美容整形手术的大量采用。此外，该国在技术开发和采用方面远远领先于其他发达国家和新兴国家，这有利于各种创新皮内注射剂的发展及其在医疗保健领域的应用。结核病 (TB) 是包括美国在内的发达国家的主要细菌感染之一。据美国疾病控制和预防中心 (CDC) 称，美国约有 1300 万人患有潜伏性结核病，而每年新诊断出 7000 多例结核病病例。由于结核菌素皮试是诊断该疾病的主要测试，因此随着结核病病例的增加，对皮内注射的需求持续增长。在美国，各种过敏反应的发生率也在增加；各种过敏是该国慢性病的第六大原因。据美国哮喘和过敏基金会称，超过 5000 万美国人经历过过敏反应。此外，每年约有 30,000 人因食物而出现过敏反应，而每年约有 7.7% 的成年人和 7.2% 的儿童会出现花粉症。在美国，医疗保健部门每年因过敏而产生的费用也在上升。随着皮肤过敏病例的激增，北美对皮内注射剂的需求也随之增加，这推动了皮内注射剂市场的增长。
北美皮内注射剂市场细分
北美皮内注射剂市场根据方法、应用、最终用户和国家/地区进行细分。根据方法，市场分为普通针、短针和无针。普通尺寸针头细分市场在 2021 年占据最大市场份额。普通尺寸针头细分市场进一步细分为皮内显微注射、微针阵列和纹身设备。短针段分为皮内液体喷射注射器和弹道皮内注射器。从应用来看，北美皮内注射剂市场分为结核菌素皮试、过敏测试、局部美容等。 2021 年，结核菌素皮试细分市场占据最大的市场份额。按最终用户划分，北美皮内注射市场分为医院、诊断实验室、学术机构和研究机构等。 2021 年，医院细分市场占据最大的市场份额。根据国家/地区，市场分为美国、加拿大和墨西哥。美国在 2021 年占据主导市场份额。
BD;西制药服务公司；泰尔茂公司；纳米通行证； PharmaJet；伊德瓦克斯；银星全球；交叉投射；康德乐健康公司；和 Hindustan Syringes and Medical Devices Ltd 是北美皮内注射市场的领先公司。”
Strategic insights for North America Intradermal Injections involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,342.54 Million |
| Market Size by 2028 | US$ 2,859.32 Million |
| Global CAGR (2021 - 2028) | 11.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 方法
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Intradermal Injections refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Intradermal Injections Market is valued at US$ 1,342.54 Million in 2021, it is projected to reach US$ 2,859.32 Million by 2028.
As per our report North America Intradermal Injections Market, the market size is valued at US$ 1,342.54 Million in 2021, projecting it to reach US$ 2,859.32 Million by 2028. This translates to a CAGR of approximately 11.4% during the forecast period.
The North America Intradermal Injections Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Intradermal Injections Market report:
The North America Intradermal Injections Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Intradermal Injections Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Intradermal Injections Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Intradermal Injections Market
